Heron Therapeutics
HRTX
HRTX
99 hedge funds and large institutions have $851M invested in Heron Therapeutics in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $1.21B → $851M (-$363M)
38% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 21
Holders
99
Holding in Top 10
5
Calls
$14.2M
Puts
$8.7M
Top Buyers
| 1 | +$31.4M | |
| 2 | +$7.71M | |
| 3 | +$6.96M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$5.62M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$2.21M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$11.1M | |
| 3 | -$8.28M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.72M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.1M |